Junfen Xu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 14
- RNA modifications and cancer 5
- DNA Repair Mechanisms 4
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 12
- Co-authors
- Weiguo Lü (30 shared papers)Xing Xie (19 shared papers)Yuanming Shen (9 shared papers)Yifeng Fang (9 shared papers)Xiaoyun Wan (4 shared papers)Fenfen Wang (5 shared papers)Feng Ye (3 shared papers)Jiansong Zhou (2 shared papers)
- Journals
- Cell Death Discovery (2 papers)Oncogene (2 papers)Clinical and Translational Medicine (2 papers)Scientific Reports (2 papers)Journal of Zhejiang University SCIENCE B (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Junfen Xu
49 papers receiving 1.7k citations
Junfen Xu's Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 835
- Molecular Biology 978
- Oncology 280
- Immunology 158
- Reproductive Medicine 54
Countries citing papers authored by Junfen Xu
This map shows the geographic impact of Junfen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfen Xu more than expected).
Fields of papers citing papers by Junfen Xu
This network shows the impact of papers produced by Junfen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfen Xu. The network helps show where Junfen Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 195 | |
| 2 | 2011 | 181 | |
| 3 | 2011 | 176 | |
| 4 | Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer Hit paper breakdown → | 2022 | 157 |
| 5 | 2014 | 133 | |
| 6 | Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy Hit paper breakdown → | 2024 | 77 |
| 7 | 2014 | 63 | |
| 8 | 2020 | 59 | |
| 9 | 2020 | 55 | |
| 10 | 2019 | 50 | |
| 11 | 2022 | 46 | |
| 12 | 2021 | 43 | |
| 13 | 2022 | 39 | |
| 14 | 2015 | 39 | |
| 15 | 2016 | 39 | |
| 16 | 2019 | 35 | |
| 17 | 2019 | 30 | |
| 18 | 2020 | 27 | |
| 19 | 2022 | 24 | |
| 20 | 2016 | 20 |
About Junfen Xu
Junfen Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Reproductive Medicine and Epidemiology, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), Circular RNAs in diseases (14 papers), MicroRNA in disease regulation (12 papers), Ovarian cancer diagnosis and treatment (9 papers), Cervical Cancer and HPV Research (6 papers), PARP inhibition in cancer therapy (5 papers), RNA modifications and cancer (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Cancer Research (835 citations), Molecular Biology (978 citations), Oncology (280 citations), Immunology (158 citations) and Reproductive Medicine (54 citations). Junfen Xu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Weiguo Lü, Xing Xie, Yuanming Shen, Yifeng Fang, Xiaoyun Wan, Fenfen Wang, Feng Ye, Jiansong Zhou, Yixuan Cen and Xiao Liang. Their work appears in journals such as Cell Death Discovery, Oncogene, Clinical and Translational Medicine, Scientific Reports and Journal of Zhejiang University SCIENCE B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.